Steris Plc (STE) - Comprehensive Stock Analysis & Investment Research
Deep dive into Steris Plc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Steris Plc Investment Summary
When evaluating whether Steris Plc (STE) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.
Company Profile
Steris Plc (STE) operates within the Industrial Applications and Services sector, specifically in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry. The company employs approximately 6,812 people. With a market capitalization of $22 billion, the company is a large-cap stock offering relative stability combined with growth potential.
Financial Performance Analysis
Our comprehensive financial analysis covers Steris Plc's revenue, profitability metrics, balance sheet strength, and cash flow generation...
AI Price Predictions
Get AI-powered 7-day, 30-day and 90-day price forecasts for Steris Plc along with confidence scores and detailed analysis...
Investment Considerations
Expert analysis of whether Steris Plc is suitable for your investment objectives, risk tolerance, and time horizon...
Corporate Identity
Steris Plc (Stock Symbol: STE) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry. The company's shares are publicly traded on the NYSE exchange.
Leadership & Workforce
Detailed information about Steris Plc's leadership team, workforce size, and organizational structure...
Market Classification
Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Steris Plc...
Sector & Industry Analysis
In-depth sector dynamics and industry context for Steris Plc...
Revenue & Growth Analysis
Steris Plc generates annual revenues of $6 billion , indicating a well-established business with proven market demand.
Profitability Metrics
Net profit margin, gross margin, and operating margin analysis for Steris Plc...
Market Valuation
P/E ratio, price-to-book, and valuation multiples for Steris Plc...
Return Metrics
Return on equity (ROE), return on assets (ROA), and capital efficiency for Steris Plc...
Strategic Market Position
Steris Plc strategically competes in the highly dynamic Orthopedic, Prosthetic & Surgical Appliances & Supplies marketplace. As a large-cap market participant, the company has established significant competitive advantages and market presence. Large-cap companies typically benefit from brand recognition, operational scale, diverse revenue streams, and the financial resources to invest in research and development, marketing, and strategic acquisitions. This size category attracts substantial institutional ownership and analyst coverage.
Industry Competitive Landscape
Steris Plc competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.
Operational Efficiency
The company shows positive operational efficiency through free cash flow generation of $397 million annually , with year-over-year cash flow growth of 16.8%. Positive free cash flow indicates the business generates more cash than required for operations and capital investments, providing resources for growth initiatives or shareholder returns.
Margin & Pricing Power Analysis
The company maintains a 43.4% gross margin indicating healthy pricing power relative to direct production costs. This margin level suggests the company has successfully differentiated its products or services, allowing it to command prices meaningfully above input costs. Maintaining these margins requires ongoing investment in brand, technology, or other differentiating factors.
Operating margin of 17.6% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. This healthy operating margin shows balanced investment in growth functions while maintaining reasonable profitability.
Asset Utilization Efficiency
Asset turnover ratio of 0.51x indicates moderate asset turnover common in capital-intensive industries such as utilities, real estate, or heavy manufacturing. Lower turnover in these sectors is expected due to the significant infrastructure required for operations.
Financial Strength & Leverage
Current ratio of 2.04 demonstrates strong short-term liquidity with current assets significantly exceeding current liabilities. This provides a substantial buffer for meeting near-term obligations and handling unexpected financial needs.